{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T01:25:23Z","timestamp":1794360323356,"version":"4.9.0"},"reference-count":113,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Duchenne muscular dystrophy (DMD) cardiomyopathy (DCM) is characterized by a hypokinetic, dilated phenotype progressively increasing with age. Regular cardiac care is crucial in DMD care. Early recognition and prophylactic use of angiotensin converting enzyme inhibitors (ACEi) are the main stay therapeutic strategy to delay incidence of DMD-DCM. Pharmacological treatment to improve symptoms and left ventricle (LV) systolic function, have been widely implemented in the past years. Because of lack of DMD specific drugs, actual indications for established DCM include current treatment for heart failure (HF). This review focuses on current HF strategies to identify, characterize, and treat DMD-DCM.<\/jats:p>","DOI":"10.3390\/jcm9103186","type":"journal-article","created":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T09:04:12Z","timestamp":1601543052000},"page":"3186","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":65,"title":["Duchenne Dilated Cardiomyopathy: Cardiac Management from Prevention to Advanced Cardiovascular Therapies"],"prefix":"10.3390","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9577-2155","authenticated-orcid":false,"given":"Rachele","family":"Adorisio","sequence":"first","affiliation":[{"name":"Heart Failure Clinic-Heart Failure, Heart Transplant, Mechanical Circulatory Support Unit, Department of Pediatric Cardiology and Cardiac Surgery, Heart and Lung Transplant, Bambino Ges\u00f9 Children\u2019s Hospital, IRCCS, 00165 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6880-3868","authenticated-orcid":false,"given":"Erica","family":"Mencarelli","sequence":"additional","affiliation":[{"name":"Heart Failure Clinic-Heart Failure, Heart Transplant, Mechanical Circulatory Support Unit, Department of Pediatric Cardiology and Cardiac Surgery, Heart and Lung Transplant, Bambino Ges\u00f9 Children\u2019s Hospital, IRCCS, 00165 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoletta","family":"Cantarutti","sequence":"additional","affiliation":[{"name":"Pediatric Cardiology and Cardiac Arrhythmias\/Syncope Unit, Department of Pediatric Cardiology and Cardiac Surgery, Bambino Ges\u00f9 Children\u2019s Hospital, IRCCS, 00165 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Calvieri","sequence":"additional","affiliation":[{"name":"Pediatric Cardiology and Cardiac Arrhythmias\/Syncope Unit, Department of Pediatric Cardiology and Cardiac Surgery, Bambino Ges\u00f9 Children\u2019s Hospital, IRCCS, 00165 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0404-1005","authenticated-orcid":false,"given":"Liliana","family":"Amato","sequence":"additional","affiliation":[{"name":"Heart Failure Clinic-Heart Failure, Heart Transplant, Mechanical Circulatory Support Unit, Department of Pediatric Cardiology and Cardiac Surgery, Heart and Lung Transplant, Bambino Ges\u00f9 Children\u2019s Hospital, IRCCS, 00165 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7577-6848","authenticated-orcid":false,"given":"Marianna","family":"Cicenia","sequence":"additional","affiliation":[{"name":"Pediatric Cardiology and Cardiac Arrhythmias\/Syncope Unit, Department of Pediatric Cardiology and Cardiac Surgery, Bambino Ges\u00f9 Children\u2019s Hospital, IRCCS, 00165 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Silvetti","sequence":"additional","affiliation":[{"name":"Pediatric Cardiology and Cardiac Arrhythmias\/Syncope Unit, Department of Pediatric Cardiology and Cardiac Surgery, Bambino Ges\u00f9 Children\u2019s Hospital, IRCCS, 00165 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adele","family":"D\u2019Amico","sequence":"additional","affiliation":[{"name":"Neuromuscolar Disease, Genetic and Rare Disease Research Area, Bambino Ges\u00f9 Children\u2019s Hospital, IRCCS, 00165 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Grandinetti","sequence":"additional","affiliation":[{"name":"Heart Failure Clinic-Heart Failure, Heart Transplant, Mechanical Circulatory Support Unit, Department of Pediatric Cardiology and Cardiac Surgery, Heart and Lung Transplant, Bambino Ges\u00f9 Children\u2019s Hospital, IRCCS, 00165 Rome, Italy"},{"name":"Department of Cardiovascular and Thoracic Sciences, Fondazione Policlinico Universitario A, Gemelli IRCCS, 20097 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Drago","sequence":"additional","affiliation":[{"name":"Pediatric Cardiology and Cardiac Arrhythmias\/Syncope Unit, Department of Pediatric Cardiology and Cardiac Surgery, Bambino Ges\u00f9 Children\u2019s Hospital, IRCCS, 00165 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Amodeo","sequence":"additional","affiliation":[{"name":"Heart Failure Clinic-Heart Failure, Heart Transplant, Mechanical Circulatory Support Unit, Department of Pediatric Cardiology and Cardiac Surgery, Heart and Lung Transplant, Bambino Ges\u00f9 Children\u2019s Hospital, IRCCS, 00165 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,10,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1016\/j.jacc.2016.02.081","article-title":"Dystrophin-Deficient Cardiomyopathy","volume":"67","author":"Kamdar","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1161\/CIRCULATIONAHA.117.028382","article-title":"Mutation-Based Therapy for Duchenne Muscular Dystrophy: Antisense Treatment Arrives in the Clinic","volume":"136","author":"McNally","year":"2017","journal-title":"Circulation"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1542\/peds.2018-0333I","article-title":"Cardiac Management of the Patient With Duchenne Muscular Dystrophy","volume":"142","author":"Buddhe","year":"2018","journal-title":"Pediatrics"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S1474-4422(18)30025-5","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 2: Respiratory, cardiac, bone health, and orthopaedic management","volume":"17","author":"Birnkrant","year":"2018","journal-title":"Lancet Neurol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.ahj.2008.01.018","article-title":"Characteristics and outcomes of cardiomyopathy in children with Duchenne or Becker muscular dystrophy: A comparative study from the Pediatric Cardiomyopathy Registry","volume":"155","author":"Connuck","year":"2008","journal-title":"Am. Heart J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S1474-4422(03)00585-4","article-title":"Dystrophin and mutations: One gene, several proteins, multiple phenotypes","volume":"2","author":"Muntoni","year":"2003","journal-title":"Lancet Neurol."},{"key":"ref_7","first-page":"97","article-title":"Cardiomyopathies: Diagnosis of types and stages","volume":"23","author":"Nigro","year":"2004","journal-title":"Acta Myol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/jama.1996.03530410049032","article-title":"Development of Cardiomyopathy in Female Carriers of Duchenne and Becker Muscular Dystrophies","volume":"275","author":"Politano","year":"1996","journal-title":"JAMA"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/0092-8674(87)90579-4","article-title":"Dystrophin: The protein product of the duchenne muscular dystrophy locus","volume":"51","author":"Hoffman","year":"1987","journal-title":"Cell"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/0092-8674(95)90344-5","article-title":"Three muscular dystrophies: Loss of cytoskeleton-extracellular matrix linkage","volume":"80","author":"Campbell","year":"1995","journal-title":"Cell"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.yjmcc.2012.12.009","article-title":"Cardiac phenotype of Duchenne Muscular Dystrophy: Insights from cellular studies","volume":"58","author":"Shirokova","year":"2013","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1146\/annurev.physiol.010908.163216","article-title":"Mechanisms of Muscle Degeneration, Regeneration, and Repair in the Muscular Dystrophies","volume":"71","author":"Wallace","year":"2009","journal-title":"Annu. Rev. Physiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1532-429X-10-50","article-title":"Cardiac involvement in patients with Becker muscular dystrophy: New diagnostic and pathophysiological insights by a CMR approach","volume":"10","author":"Yilmaz","year":"2008","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0046-8177(76)80053-6","article-title":"The pathology of the heart in progressive muscular dystrophy: Epimyocardial fibrosis","volume":"7","author":"Frankel","year":"1976","journal-title":"Hum. Pathol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1474-4422(09)70272-8","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 2: Implementation of multidisciplinary care","volume":"9","author":"Bushby","year":"2010","journal-title":"Lancet Neurol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0960-8966(02)00140-2","article-title":"Survival in Duchenne muscular dystrophy: Improvements in life expectancy since 1967 and the impact of home nocturnal ventilation","volume":"12","author":"Eagle","year":"2002","journal-title":"Neuromuscul. Disord."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0167-5273(90)90082-G","article-title":"The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy","volume":"26","author":"Nigro","year":"1990","journal-title":"Int. J. Cardiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1093\/clinchem\/47.3.451","article-title":"Clinical and Experimental Results on Cardiac Troponin Expression in Duchenne Muscular Dystrophy","volume":"47","author":"Erlacher","year":"2001","journal-title":"Clin. Chem."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.nmd.2011.02.016","article-title":"Idebenone as a novel, therapeutic approach for Duchenne muscular dystrophy: Results from a 12 month, double-blind, randomized placebo-controlled trial","volume":"21","author":"Buyse","year":"2011","journal-title":"Neuromuscul. Disord."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.braindev.2008.09.006","article-title":"Cardiac troponin I for accurate evaluation of cardiac status in myopathic patients","volume":"31","year":"2009","journal-title":"Brain Dev."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Voleti, S., Olivieri, L., Hamann, K., Gordish-Dressman, H., and Spurney, C. (2020). Troponin I Levels Correlate with Cardiac MR LGE and Native T1 Values in Duchenne Muscular Dystrophy Cardiomyopathy and Identify Early Disease Progression. Pediatr. Cardiol., 1\u20137.","DOI":"10.1007\/s00246-020-02372-5"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/0002-8703(90)90130-P","article-title":"Plasma levels of atrial natriuretic peptide in patients with Duchenne\u2019s progressive muscular dystrophy","volume":"120","author":"Yanagisawa","year":"1990","journal-title":"Am. Heart J."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.nmd.2016.07.010","article-title":"Identifying evidence of cardio-renal syndrome in patients with Duchenne muscular dystrophy using cystatin C","volume":"26","author":"Villa","year":"2016","journal-title":"Neuromuscul. Disord."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.nmd.2018.05.011","article-title":"Imaging the heart to detect cardiomyopathy in Duchenne muscular dystrophy: A review","volume":"28","author":"Power","year":"2018","journal-title":"Neuromuscul. Disord."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.echo.2016.07.001","article-title":"Evaluation of Echocardiographic Measures of Left Ventricular Function in Patients with Duchenne Muscular Dystrophy: Assessment of Reproducibility and Comparison to Cardiac Magnetic Resonance Imaging","volume":"29","author":"Soslow","year":"2016","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1007\/s00247-016-3622-y","article-title":"Comparison of left ventricular function assessment between echocardiography and MRI in Duchenne muscular dystrophy","volume":"46","author":"Buddhe","year":"2016","journal-title":"Pediatr. Radiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.amjcard.2018.12.011","article-title":"Evaluation of Left-Sided Heart Chambers with Novel Echocardiographic Techniques in Men With Duchenne or Becker Muscular Dystrophy","volume":"123","author":"Cirino","year":"2019","journal-title":"Am. J. Cardiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.echo.2015.03.003","article-title":"Feasibility and Reproducibility of Echocardiographic Measures in Children with Muscular Dystrophies","volume":"28","author":"Spurney","year":"2015","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.echo.2015.11.016","article-title":"Reference Ranges of Left Ventricular Strain Measures by Two-Dimensional Speckle-Tracking Echocardiography in Children: A Systematic Review and Meta-Analysis","volume":"29","author":"Levy","year":"2016","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1530\/ERP-14-0070","article-title":"Two-dimensional global and segmental longitudinal strain: Are the results from software in different high-end ultrasound systems comparable?","volume":"2","author":"Patrianakos","year":"2015","journal-title":"Echo Res. Pr."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.echo.2018.10.017","article-title":"Speckle-Tracking Echocardiography in Children with Duchenne Muscular Dystrophy: A Prospective Multicenter Controlled Cross-Sectional Study","volume":"32","author":"Amedro","year":"2019","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3389\/fcvm.2017.00082","article-title":"Echocardiographic Image Quality Deteriorates with Age in Children and Young Adults with Duchenne Muscular Dystrophy","volume":"4","author":"Power","year":"2017","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.ejrad.2015.07.007","article-title":"Comparison of right and left ventricular function and size in Duchenne muscular dystrophy","volume":"84","author":"Mehmood","year":"2015","journal-title":"Eur. J. Radiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1001\/jamacardio.2016.4801","article-title":"Myocardial Fibrosis Progression in Duchenne and Becker Muscular Dystrophy","volume":"2","author":"Silva","year":"2017","journal-title":"JAMA Cardiol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S1474-4422(14)70318-7","article-title":"Eplerenone for early cardiomyopathy in Duchenne muscular dystrophy: A randomised, double-blind, placebo-controlled trial","volume":"14","author":"Raman","year":"2014","journal-title":"Lancet Neurol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1093\/ehjci\/jev161","article-title":"Cardiac involvement in female Duchenne and Becker muscular dystrophy carriers in comparison to their first-degree male relatives: A comparative cardiovascular magnetic resonance study","volume":"17","author":"Florian","year":"2015","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1007\/s00246-015-1192-7","article-title":"Myocardial Fibrosis and Left Ventricular Dysfunction in Duchenne Muscular Dystrophy Carriers Using Cardiac Magnetic Resonance Imaging","volume":"36","author":"Lang","year":"2015","journal-title":"Pediatr. Cardiol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s12968-014-0081-1","article-title":"Left ventricular systolic function and the pattern of late-gadolinium-enhancement independently and additively predict adverse cardiac events in muscular dystrophy patients","volume":"16","author":"Florian","year":"2014","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"410","DOI":"10.4330\/wjc.v7.i7.410","article-title":"Cardiac involvement in Duchenne and Becker muscular dystrophy","volume":"7","author":"Mavrogeni","year":"2015","journal-title":"World J. Cardiol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1532-429X-16-45","article-title":"Patterns of late gadolinium enhancement in Duchenne muscular dystrophy carriers","volume":"16","author":"Giglio","year":"2014","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12968-016-0281-y","article-title":"Myocardial late gadolinium enhancement is associated with clinical presentation in Duchenne muscular dystrophy carriers","volume":"18","author":"Wexberg","year":"2016","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e001338","DOI":"10.1161\/JAHA.114.001338","article-title":"Myocardial Fibrosis Burden Predicts Left Ventricular Ejection Fraction and Is Associated with Age and Steroid Treatment Duration in Duchenne Muscular Dystrophy","volume":"4","author":"Tandon","year":"2015","journal-title":"J. Am. Heart Assoc."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12968-016-0292-8","article-title":"Native T1 values identify myocardial changes and stratify disease severity in patients with Duchenne muscular dystrophy","volume":"18","author":"Olivieri","year":"2016","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12968-016-0224-7","article-title":"Increased myocardial native T1 and extracellular volume in patients with Duchenne muscular dystrophy","volume":"18","author":"Soslow","year":"2015","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1148\/radiol.14140296","article-title":"Accuracy, precision, and reproducibility of four T1 mapping sequences: A head-to-head comparison of MOLLI, ShMOLLI, SASHA, and SAPPHIRE","volume":"272","author":"Roujol","year":"2014","journal-title":"Radiology"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12968-015-0136-y","article-title":"Characterization of myocardial T1-mapping bias caused by intramyocardial fat in inversion recovery and saturation recovery techniques","volume":"17","author":"Kellman","year":"2015","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s00246-017-1777-4","article-title":"Myocardial Strain Using Cardiac MR Feature Tracking and Speckle Tracking Echocardiography in Duchenne Muscular Dystrophy Patients","volume":"39","author":"Siegel","year":"2017","journal-title":"Pediatr. Cardiol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1007\/s00246-018-2046-x","article-title":"Progressive left ventricular dysfunction and myocardial fibrosis in Duchenne and Becker muscular dystrophy: A longitudinal cardiovascular magnetic resonance study","volume":"40","author":"Aikawa","year":"2018","journal-title":"Pediatr. Cardiol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur. Heart J."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.jacc.2004.09.078","article-title":"Effect of perindopril on the onset and progression of left ventricular dysfunction in Duchenne muscular dystrophy","volume":"45","author":"Duboc","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Allen, H.D., Flanigan, K.M., Thrush, P.T., Dvorchik, I., Yin, H., Canter, C., Connolly, A.M., Parrish, M., McDonald, C.M., and Braunlin, E. (2013). A Randomized, Double-Blind Trial of Lisinopril and Losartan for the Treatment of Cardiomyopathy in Duchenne Muscular Dystrophy. PLoS Curr., 5.","DOI":"10.1371\/currents.md.2cc69a1dae4be7dfe2bcb420024ea865"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"e013501","DOI":"10.1161\/JAHA.119.013501","article-title":"Stabilization of Early Duchenne Cardiomyopathy With Aldosterone Inhibition: Results of the Multicenter AIDMD Trial","volume":"8","author":"Raman","year":"2019","journal-title":"J. Am. Heart Assoc."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00246-007-9113-z","article-title":"Safety and Efficacy of Carvedilol Therapy for Patients with Dilated Cardiomyopathy Secondary to Muscular Dystrophy","volume":"29","author":"Rhodes","year":"2007","journal-title":"Pediatr. Cardiol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/ehf2.12165","article-title":"Clinical profiles and prognosis of acute heart failure in adult patients with dystrophinopathies on home mechanical ventilation","volume":"4","author":"Fayssoil","year":"2017","journal-title":"ESC Heart Fail."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1161\/CIRCULATIONAHA.104.528281","article-title":"Genetic Predictors and Remodeling of Dilated Cardiomyopathy in Muscular Dystrophy","volume":"112","author":"Jefferies","year":"2005","journal-title":"Circulation"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1253\/circj.70.991","article-title":"Beta-blocker therapy for cardiac dysfunction in patients with muscular dystrophy","volume":"70","author":"Kajimoto","year":"2006","journal-title":"Circ. J."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.2169\/internalmedicine.49.3259","article-title":"Carvedilol can prevent cardiac events in Duchenne muscular dystrophy","volume":"49","author":"Matsumura","year":"2010","journal-title":"Intern. Med."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jjcc.2008.08.013","article-title":"Beneficial effects of beta-blockers and angiotensin-converting enzyme inhibitors in Duchenne muscular dystrophy","volume":"53","author":"Ogata","year":"2009","journal-title":"J. Cardiol."},{"key":"ref_59","first-page":"691","article-title":"Carvedilol effectiveness for left ventricular-insufficient patients with Duchenne muscular dystrophy","volume":"41","author":"Saito","year":"2001","journal-title":"Rinsho Shinkeigaku"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.amjcard.2012.02.064","article-title":"Effects of Angiotensin-Converting Enzyme Inhibitors and\/or Beta Blockers on the Cardiomyopathy in Duchenne Muscular Dystrophy","volume":"110","author":"Viollet","year":"2012","journal-title":"Am. J. Cardiol."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Meyers, T.A., and Townsend, D. (2019). Cardiac Pathophysiology and the Future of Cardiac Therapies in Duchenne Muscular Dystrophy. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20174098"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ijcard.2019.01.052","article-title":"Heart rate reduction strategy using ivabradine in end-stage Duchenne cardiomyopathy","volume":"280","author":"Adorisio","year":"2019","journal-title":"Int. J. Cardiol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.jacc.2017.07.725","article-title":"Ivabradine in Children With Dilated Cardiomyopathy and Symptomatic Chronic Heart Failure","volume":"70","author":"Bonnet","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: A report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.steroids.2018.02.010","article-title":"Phase 1 trial of vamorolone, a first-in-class steroid, shows improvements in side effects via biomarkers bridged to clinical outcomes","volume":"134","author":"Hoffman","year":"2018","journal-title":"Steroids"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ahj.2017.07.006","article-title":"Design for the sacubitril\/valsartan (LCZ696) compared with enalapril study of pediatric patients with heart failure due to systemic left ventricle systolic dysfunction (PANORAMA-HF study)","volume":"193","author":"Shaddy","year":"2017","journal-title":"Am. Heart J."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Das, B.B. (2018). Current State of Pediatric Heart Failure. Children, 5.","DOI":"10.3390\/children5070088"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/ejhf.1369","article-title":"The use of diuretics in heart failure with congestion\u2014A position statement from the Heart Failure Association of the European Society of Cardiology","volume":"21","author":"Mullens","year":"2019","journal-title":"Eur. J. Heart Fail."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/BF00794837","article-title":"The effect of treatment with angiotensin-converting enzyme inhibitors on survival of pediatric patients with dilated cardiomyopathy","volume":"14","author":"Lewis","year":"1993","journal-title":"Pediatr. Cardiol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.healun.2014.06.002","article-title":"The International Society for Heart and Lung Transplantation Guidelines for the management of pediatric heart failure: Executive summary","volume":"33","author":"Kirk","year":"2014","journal-title":"J. Heart Lung Transpl."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1136\/heartjnl-2017-311269","article-title":"A current approach to heart failure in Duchenne muscular dystrophy","volume":"103","author":"Amodeo","year":"2017","journal-title":"Heart"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1161\/CIRCULATIONAHA.114.015151","article-title":"Contemporary Cardiac Issues in Duchenne Muscular Dystrophy","volume":"131","author":"McNally","year":"2015","journal-title":"Circulation"},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Piperata, A., Bottio, T., Toscano, G., Avesani, M., Vianello, A., and Gerosa, G. (2020). Is heart transplantation a real option in patients with Duchenne syndrome? Inferences from a case report. ESC Heart Fail.","DOI":"10.1002\/ehf2.12905"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1056\/NEJMoa012175","article-title":"Long-Term Use of a Left Ventricular Assist Device for End-Stage Heart Failure","volume":"345","author":"Rose","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1016\/j.jacc.2010.10.062","article-title":"Results of the Post-U.S. Food and Drug Administration-Approval Study with a Continuous Flow Left Ventricular Assist Device as a Bridge to Heart Transplantation","volume":"57","author":"Starling","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1056\/NEJMoa0909938","article-title":"Advanced Heart Failure Treated with Continuous-Flow Left Ventricular Assist Device","volume":"361","author":"Slaughter","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.pcad.2016.01.006","article-title":"Mechanical Circulatory Support: Current Status and Future Directions","volume":"58","author":"Enciso","year":"2016","journal-title":"Prog. Cardiovasc. Dis."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/00002480-199807000-00011","article-title":"Neurohormonal changes after implantation of a left ventricular assist system","volume":"44","author":"Delgado","year":"1998","journal-title":"ASAIO J."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1161\/hc3101.093903","article-title":"Comparison of Right and Left Ventricular Responses to Left Ventricular Assist Device Support in Patients with Severe Heart Failure","volume":"104","author":"Barbone","year":"2001","journal-title":"Circulation"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1067\/mtc.2001.112632","article-title":"Time course of reverse remodeling of the left ventricle during support with a left ventricular assist device","volume":"121","author":"Madigan","year":"2001","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1161\/CIRCULATIONAHA.104.515106","article-title":"Mechanical Unloading During Left Ventricular Assist Device Support Increases Left Ventricular Collagen Cross-Linking and Myocardial Stiffness","volume":"112","author":"Klotz","year":"2005","journal-title":"Circulation"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1161\/01.CIR.91.11.2717","article-title":"Reversal of Chronic Ventricular Dilation in Patients With End-Stage Cardiomyopathy by Prolonged Mechanical Unloading","volume":"91","author":"Levin","year":"1995","journal-title":"Circulation"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1161\/01.CIR.98.7.656","article-title":"Regression of cellular hypertrophy after left ventricular assist device support","volume":"98","author":"Zafeiridis","year":"1998","journal-title":"Circulation"},{"key":"ref_84","first-page":"765","article-title":"Altered myocardial phenotype after mechanical support in human beings with advanced cardiomyopathy","volume":"16","author":"Altemose","year":"1997","journal-title":"J. Heart Lung Transpl."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1161\/01.CIR.97.23.2316","article-title":"Myocyte recovery after mechanical circulatory support in humans with end-stage heart failure","volume":"97","author":"Dipla","year":"1998","journal-title":"Circulation"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1016\/j.ijcard.2012.04.009","article-title":"Left ventricular assist device in Duchenne Cardiomyopathy: Can we change the natural history of cardiac disease?","volume":"161","author":"Amodeo","year":"2012","journal-title":"Int. J. Cardiol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1016\/j.transproceed.2012.06.034","article-title":"Ventricular Assist Devices as a Bridge to Heart Transplantation or as Destination Therapy in Pediatric Patients","volume":"44","author":"Brancaccio","year":"2012","journal-title":"Transpl. Proc."},{"key":"ref_88","first-page":"2158","article-title":"Dealing with surgical left ventricular assist device complications","volume":"7","author":"Kilic","year":"2015","journal-title":"J. Thorac. Dis."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/MAT.0000000000000050","article-title":"Implantation of the HeartMate II and HeartWare Left Ventricular Assist Devices in Patients With Duchenne Muscular Dystrophy","volume":"60","author":"Ryan","year":"2014","journal-title":"ASAIO J."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.nmd.2014.08.008","article-title":"Implantation of a left ventricular assist device as a destination therapy in Duchenne muscular dystrophy patients with end stage cardiac failure: Management and lessons learned","volume":"25","author":"Iodice","year":"2015","journal-title":"Neuromuscul. Disord."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/ehf2.12160","article-title":"Implantation of a left ventricular assist device to provide long-term support for end-stage Duchenne muscular dystrophy-associated cardiomyopathy","volume":"4","author":"Stoller","year":"2017","journal-title":"ESC Heart Fail."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.jtcvs.2016.08.016","article-title":"Left ventricular assist device as destination therapy in cardiac end-stage dystrophinopathies: Midterm results","volume":"153","author":"Perri","year":"2017","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ppedcard.2019.01.001","article-title":"Use of advanced heart failure therapies in Duchenne muscular dystrophy","volume":"53","author":"Villa","year":"2019","journal-title":"Prog. Pediatr. Cardiol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1007\/s00246-018-1889-5","article-title":"Cost-Effectiveness of Ventricular Assist Device Destination Therapy for Advanced Heart Failure in Duchenne Muscular Dystrophy","volume":"39","author":"Magnetta","year":"2018","journal-title":"Pediatr. Cardiol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1002\/ehf2.12286","article-title":"Comment on: \u2019Implantation of a left ventricular assist device to provide long term support for end-stage Duchenne muscular dystrophy-associated cardiomyopathy","volume":"5","author":"Adorisio","year":"2018","journal-title":"ESC Heart Fail."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.pcl.2007.07.008","article-title":"Collaborative Communication in Pediatric Palliative Care: A Foundation for Problem-Solving and Decision-Making","volume":"54","author":"Feudtner","year":"2007","journal-title":"Pediatr. Clin. N. Am."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1016\/j.jacc.2018.08.2182","article-title":"Cardiac Phenotypes in Hereditary Muscle Disorders","volume":"72","author":"Arbustini","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3233\/JND-160194","article-title":"Cardiac Involvement Classification and Therapeutic Management in Patients with Duchenne Muscular Dystrophy","volume":"4","author":"Fayssoil","year":"2017","journal-title":"J. Neuromuscul. Dis."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Fayssoil, A., Ben Yaou, R., Ogna, A., Chaffaut, C., Leturcq, F., Nardi, O., Wahbi, K., Duboc, D., Lofaso, F., and Prigent, H. (2018). Left bundle branch block in Duchenne muscular dystrophy: Prevalence, genetic relationship and prognosis. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0190518"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/S0735-1097(84)80186-2","article-title":"Cardiac rhythm and conduction in Duchenne\u2019s muscular dystrophy: A prospective study of 20 patients","volume":"3","author":"Perloff","year":"1984","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0002-9149(02)02195-1","article-title":"Prognostic value of electrocardiograms, ventricular late potentials, ventricular arrhythmias, and left ventricular systolic dysfunction in patients with Duchenne muscular dystrophy","volume":"89","author":"Corrado","year":"2002","journal-title":"Am. J. Cardiol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"e8335","DOI":"10.1097\/MD.0000000000008335","article-title":"Cardiac conduction disturbances and aging in patients with Duchenne muscular dystrophy","volume":"96","author":"Segawa","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"e12477","DOI":"10.1111\/anec.12477","article-title":"Electrical storm in a patient with Duchenne muscular dystrophy cardiomyopathy triggered by abrupt \u03b2-blocker interruption","volume":"22","author":"Fragakis","year":"2017","journal-title":"Ann. Noninvasive Electrocardiol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"130091","DOI":"10.1172\/jci.insight.130091","article-title":"S-nitrosylation of connexin43 hemichannels elicits cardiac stress-induced arrhythmias in Duchenne muscular dystrophy mice","volume":"4","author":"Lillo","year":"2019","journal-title":"JCI Insight"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"e005682","DOI":"10.1161\/CIRCEP.117.005682","article-title":"Oxidized CaMKII (Ca2+\/Calmodulin-Dependent Protein Kinase II) Is Essential for Ventricular Arrhythmia in a Mouse Model of Duchenne Muscular Dystrophy","volume":"11","author":"Wang","year":"2018","journal-title":"Circ. Arrhythmia Electrophysiol."},{"key":"ref_106","first-page":"1","article-title":"Are there real benefits to implanting cardiac devices in patients with end-stage dilated dystrophinopathic cardiomyopathy? Review of literature and personal results","volume":"38","author":"Palladino","year":"2019","journal-title":"Acta Myol."},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"D\u2019Amario, D., Gowran, A., Canonico, F., Castiglioni, E., Rovina, D., Santoro, R., Spinelli, P., Adorisio, R., Amodeo, A., and Perrucci, G.L. (2018). Dystrophin Cardiomyopathies: Clinical Management, Molecular Pathogenesis and Evolution towards Precision Medicine. J. Clin. Med., 7.","DOI":"10.3390\/jcm7090291"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1212\/WNL.0000000000001950","article-title":"Prednisone\/prednisolone and deflazacort regimens in the CINRG Duchenne Natural History Study","volume":"85","author":"Bello","year":"2015","journal-title":"Neurology"},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Lim, K.R.Q., Sheri, N., Nguyen, Q., and Yokota, T. (2020). Cardiac Involvement in Dystrophin-Deficient Females: Current Understanding and Implications for the Treatment of Dystrophinopathies. Genes, 11.","DOI":"10.3390\/genes11070765"},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Brioschi, S., Gualandi, F., Scotton, C., Armaroli, A., Bovolenta, M., Falzarano, M.S., Sabatelli, P., Selvatici, R., D\u2019Amico, A., and Pane, M. (2012). Genetic characterization in symptomatic female DMD carriers: Lack of relationship between X-inactivation, transcriptional DMD allele balancing and phenotype. BMC Med. Genet., 13.","DOI":"10.1186\/1471-2350-13-73"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jns.2018.03.015","article-title":"Muscle, cardiac, and cerebral manifestations in female carriers of dystrophin variants","volume":"388","author":"Finsterer","year":"2018","journal-title":"J. Neurol. Sci."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.nmd.2018.04.005","article-title":"Female dystrophinopathy: Review of current literature","volume":"28","author":"Ishizaki","year":"2018","journal-title":"Neuromuscul. Disord."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2169\/internalmedicine.39.2","article-title":"Cardiac involvement of female carrier of Duchenne muscular dystrophy","volume":"39","author":"Kamakura","year":"2000","journal-title":"Intern. Med."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/9\/10\/3186\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:15:34Z","timestamp":1760177734000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/9\/10\/3186"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,1]]},"references-count":113,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,10]]}},"alternative-id":["jcm9103186"],"URL":"https:\/\/doi.org\/10.3390\/jcm9103186","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,1]]}}}